Stenbäck F - Search Results

1

Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.

Launonen V, Stenbäck F, Puistola U, Bloigu R, Huusko P, Kytölä S, Kauppila A, Winqvist R. Launonen V, et al. Among authors: stenback f. Gynecol Oncol. 1998 Nov;71(2):299-304. doi: 10.1006/gyno.1998.5186. Gynecol Oncol. 1998. PMID: 9826475

2

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables.

Launonen V, Mannermaa A, Stenbäck F, Kosma VM, Puistola U, Huusko P, Anttila M, Bloigu R, Saarikoski S, Kauppila A, Winqvist R. Launonen V, et al. Among authors: stenback f. Cancer Genet Cytogenet. 2000 Oct 1;122(1):49-54. doi: 10.1016/s0165-4608(00)00279-x. Cancer Genet Cytogenet. 2000. PMID: 11104033

3

Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary.

Santala M, Burger H, Ruokonen A, Stenbäck F, Kauppila A. Santala M, et al. Among authors: stenback f. Gynecol Oncol. 1998 Dec;71(3):465-8. doi: 10.1006/gyno.1998.5191. Gynecol Oncol. 1998. PMID: 9887252

4

Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study.

Zhu GG, Stenbäck F, Risteli L, Risteli J, Kauppila A. Zhu GG, et al. Among authors: stenback f. Cancer. 1993 Sep 1;72(5):1679-84. doi: 10.1002/1097-0142(19930901)72:5<1679::aid-cncr2820720531>3.0.co;2-w. Cancer. 1993. PMID: 8348501

5

Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas.

Kauppila S, Saarela J, Stenbäck F, Risteli J, Kauppila A, Risteli L. Kauppila S, et al. Among authors: stenback f. Am J Pathol. 1996 Feb;148(2):539-48. Am J Pathol. 1996. PMID: 8579116 Free PMC article.

6

Measurement of epithelial and stromal changes in vulvar carcinoma - a clinical, biochemical and immunohistochemical study.

Tomas C, Risteli J, Risteli L, Stenback F, Kauppila A. Tomas C, et al. Among authors: stenback f. Int J Oncol. 1995 Jul;7(1):101-5. Int J Oncol. 1995. PMID: 21552813

7

Endometrioid ovarian tumors: morphology and relation to other endometrial conditions.

Stenbäck F, Kauppila A. Stenbäck F, et al. Gynecol Obstet Invest. 1981;12(2):57-70. doi: 10.1159/000299569. Gynecol Obstet Invest. 1981. PMID: 7262634

8

Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms.

Zhu GG, Risteli L, Mäkinen M, Risteli J, Kauppila A, Stenbäck F. Zhu GG, et al. Among authors: stenback f. Cancer. 1995 Feb 15;75(4):1010-7. doi: 10.1002/1097-0142(19950215)75:4<1010::aid-cncr2820750417>3.0.co;2-o. Cancer. 1995. PMID: 7842402

9

Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapy.

Kauppila A, Kivinen S, Stenbäck F, Vihko R, Vuopala S. Kauppila A, et al. Among authors: stenback f. Gynecol Obstet Invest. 1988;25(1):58-65. doi: 10.1159/000293746. Gynecol Obstet Invest. 1988. PMID: 3277903 Clinical Trial.

10

Cytosolic estrogen and progestin receptors in human endometrium from different regions of the uterus.

Kauppila A, Jänne O, Stenbäck F, Vihko R. Kauppila A, et al. Among authors: stenback f. Gynecol Oncol. 1982 Oct;14(2):225-9. doi: 10.1016/0090-8258(82)90094-4. Gynecol Oncol. 1982. PMID: 6290350 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters